Background: Gingival overgrowth caused by calcium channel blockers is a well-known adverse effect. Most of this evidence has come from case reports, and there have been a few prevalence studies to evaluate the magnitude of this effect. However, since the number of patients examined in these studies were small, the prevalence of gingival overgrowth is uncertain. Objective: The incidences of gingival overgrowth of 13 calcium channel blockers were determined. Methods: Dental patients (n = 1,315) who received one of 13 calcium channel blockers for more than 3 months were surveyed to determine the drug-induced gingival overgrowth. Of these, 158 were taking amlodipine, 25 barnidipine, 28 benidipine, 46 cinnarizine, 184 diltiazem, 32 flunarizine, 109 manidipine, 214 nicardipine, 307 nifedipine, 58 nilvadipine, 87 nisoldipine, 25 nitrendipine and 41verapamil. Patients taking other drugs known to induce gingival overgrowth or presenting with complaint of drug-induced gingival overgrowth were excluded from this study. Clinical diagnosis of drug-induced overgrowth was verified by disappearance or decreased severity of gingival overgrowth after withdrawal of the causative drug. Results: The gingival overgrowth was found in patients receiving amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine, but not by barnidipine, benidipine, cinnarizine, flunarizine, nilvadipine, nitrendipine and verapamil (Table 1 ). The clinical finding of gingival overgrowth was the same among drugs. The highest incidence of gingival overgrowth was obtained by nifedipine (8.1%), followed by diltiazem (4.3%), amlodipine (1.9%), manidipine (1.8%), nisoldipine (1.1%) and nicardipine (0.5%). The incidence of nifedipine-induced gingival overgrowth was significantly higher than those of amlodipine, manidipine nicardipine and nisoldipine, but not diltiazem. Discussion: Previous reports concerning prevalence of calcium channel blocker-related gingival overgrowth with more than 100 sample size are summarized in Table 2 . The incidence of nifedipine-induced gingival overgrowth varied from 6.3 to 43.6% (1-3). That of amlodipine was 1.7 and 3.3% (3, 4) . The present results of nifedipine (8.1%) and amlodipine (1.9%) were similar to those of Katsumi (1) and Ellis (3) and that of Ellis (3), respectively.
Conclusions: Gingival overgrowth induced by amlodipine, diltiazem, manidipine, nicardipine, nifedipine and nisoldipine was found in surveyed patients, of which incidence of overgrowth varied among the drugs. Calcium channel blocker-induced gingival overgrowth, especially by nifedipine, appears more frequently and is now not a rare adverse effect. 
